---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-064319"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2021-12-09T23:59:59+00:00"
generated_at: "2026-06-28T02:24:16.849494+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Adial Pharmaceuticals appoints Cary Claiborne as COO effective Dec 6, 2021

## Summary
- Cary Claiborne appointed COO; continues to serve on Board of Directors.
- Employment agreement: $304,000 base salary, 25% target bonus, three-year term.
- Awarded option to purchase 130,000 shares at $2.77, vesting monthly over 36 months.
- Joseph Truluck resigns as COO but remains CFO of the company.
- Press release issued December 8, 2021 announcing the appointment.

## SEC filing metadata
- accession: 0001213900-21-064319
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2021-12-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390021064319/0001213900-21-064319-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390021064319/ea151938-8k_adialpharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-064319
- JSON: https://secwatch.observer/filing/0001213900-21-064319.json
- Plain text: https://secwatch.observer/filing/0001213900-21-064319.txt

## Key facts
- Executive change
  Cary Claiborne was appointed as Chief Operating Officer at ADIAL PHARMACEUTICALS, INC..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On December 6, 2021, Adial Pharmaceuticals, Inc. (the “Company”) appointed Cary Claiborne as the Company’s Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1513525/000121390021064319/0001213900-21-064319-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.